Oxford PharmaGenesis has been named as one of the ‘1000 Companies to Inspire Britain’ in a report published this week by the London Stock Exchange Group.

At the April MedComms Brunch Club in Oxford, expert insights into the latest trends and industry updates were presented by Dr Chris Winchester, our Managing Director, Dr Paul Farrow, Communications Director, and Saundra Hemmings, Project Manager.

Oxford PharmaGenesis Commercial Director Dr Richard White was Chairman of the 16th Annual Meeting of The International Publication Planning Association (TIPPA), held in San Diego, USA on 21–22 February 2017, and provides his insights on the conference.

Teams across the Oxford PharmaGenesis offices have been celebrating Pi Day after more than 100 of us registered with ORCID, joining a community of over 3.14 million people who share the vision of transparency and trust in research and innovation.

As a leading healthcare communications company and a proud member of the Reciprocate network, Oxford PharmaGenesis takes its corporate social responsibilities very seriously.

Today, 28 February 2017, marks the 10th international Rare Disease Day and this year’s theme is ‘Research‘.